The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population

Background: Diversity in response on exposure to severe acute respiratory syndrome coronavirus 2 may be related to the innate immune response in the elderly. The mucin MUC5B is an important component of the innate immune response and expression levels are associated with the MUC5B promoter polymorph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Coline H. M. van Moorsel, Joanne J. van der Vis, Anna Duckworth, Chris J. Scotton, Claudia Benschop, David Ellinghaus, Henk J. T. Ruven, Marian J. R. Quanjel, Jan C. Grutters
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/74b3faf17a3a41a2bee1cbf580255bc2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74b3faf17a3a41a2bee1cbf580255bc2
record_format dspace
spelling oai:doaj.org-article:74b3faf17a3a41a2bee1cbf580255bc22021-11-30T13:24:19ZThe MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population2296-858X10.3389/fmed.2021.668024https://doaj.org/article/74b3faf17a3a41a2bee1cbf580255bc22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.668024/fullhttps://doaj.org/toc/2296-858XBackground: Diversity in response on exposure to severe acute respiratory syndrome coronavirus 2 may be related to the innate immune response in the elderly. The mucin MUC5B is an important component of the innate immune response and expression levels are associated with the MUC5B promoter polymorphism, rs35705950. The high expressing T-allele is a risk allele for the non-infectious aging lung disease idiopathic pulmonary fibrosis (IPF). We investigated if MUC5B rs35705950 associates with severe COVID-19.Methods: In this retrospective candidate gene case-control study we recruited 108 Dutch patients (69% male, median age 66 years, 77% white) requiring hospitalization for COVID-19 (22% ICU stay, 24% died). For validation, genotypes were obtained from the UK-Biobank (n = 436, 57% male, median age 70 years, 27% died), for replication data from the severe COVID-19 GWAS group from Italy (n = 835) and Spain (n = 775) was used, each with a control cohort (n = 356,735, n = 1,255, n = 950, respectively). MUC5B association analysis was performed including adjustment for age and sex.Results: The rs35705950 T-allele frequency was significantly lower in Dutch white patients (n = 83) than in controls (0.04 vs. 0.10; p = 0.02). This was validated in the UK biobank cohort (0.08 vs. 0.11; p = 0.001). While age and sex differed significantly between cases and control, comparable results were obtained with age and sex as confounding variables in a multivariate analysis. The association was replicated in the Italian (p = 0.04), and Spanish (p = 0.03) case-control cohorts. Meta-analysis showed a negative association for the T-allele with COVID-19 (OR = 0.75 (CI: 0.67–0.85); p = 6.63 × 10−6).Conclusions: This study shows that carriage of the T-allele of MUC5B rs35705950 confers protection from development of severe COVID-19. Because the T-allele is a known risk allele for IPF, this study provides further evidence for the existence of trade-offs between optimal mucin expression levels in the aging lung.Coline H. M. van MoorselColine H. M. van MoorselJoanne J. van der VisJoanne J. van der VisAnna DuckworthChris J. ScottonClaudia BenschopClaudia BenschopDavid EllinghausDavid EllinghausHenk J. T. RuvenMarian J. R. QuanjelJan C. GruttersJan C. GruttersFrontiers Media S.A.articleMUC5BCOVID-19idiopathic pulmonary fibrosisinnate immunitymucusSARS-CoV-2Medicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic MUC5B
COVID-19
idiopathic pulmonary fibrosis
innate immunity
mucus
SARS-CoV-2
Medicine (General)
R5-920
spellingShingle MUC5B
COVID-19
idiopathic pulmonary fibrosis
innate immunity
mucus
SARS-CoV-2
Medicine (General)
R5-920
Coline H. M. van Moorsel
Coline H. M. van Moorsel
Joanne J. van der Vis
Joanne J. van der Vis
Anna Duckworth
Chris J. Scotton
Claudia Benschop
Claudia Benschop
David Ellinghaus
David Ellinghaus
Henk J. T. Ruven
Marian J. R. Quanjel
Jan C. Grutters
Jan C. Grutters
The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
description Background: Diversity in response on exposure to severe acute respiratory syndrome coronavirus 2 may be related to the innate immune response in the elderly. The mucin MUC5B is an important component of the innate immune response and expression levels are associated with the MUC5B promoter polymorphism, rs35705950. The high expressing T-allele is a risk allele for the non-infectious aging lung disease idiopathic pulmonary fibrosis (IPF). We investigated if MUC5B rs35705950 associates with severe COVID-19.Methods: In this retrospective candidate gene case-control study we recruited 108 Dutch patients (69% male, median age 66 years, 77% white) requiring hospitalization for COVID-19 (22% ICU stay, 24% died). For validation, genotypes were obtained from the UK-Biobank (n = 436, 57% male, median age 70 years, 27% died), for replication data from the severe COVID-19 GWAS group from Italy (n = 835) and Spain (n = 775) was used, each with a control cohort (n = 356,735, n = 1,255, n = 950, respectively). MUC5B association analysis was performed including adjustment for age and sex.Results: The rs35705950 T-allele frequency was significantly lower in Dutch white patients (n = 83) than in controls (0.04 vs. 0.10; p = 0.02). This was validated in the UK biobank cohort (0.08 vs. 0.11; p = 0.001). While age and sex differed significantly between cases and control, comparable results were obtained with age and sex as confounding variables in a multivariate analysis. The association was replicated in the Italian (p = 0.04), and Spanish (p = 0.03) case-control cohorts. Meta-analysis showed a negative association for the T-allele with COVID-19 (OR = 0.75 (CI: 0.67–0.85); p = 6.63 × 10−6).Conclusions: This study shows that carriage of the T-allele of MUC5B rs35705950 confers protection from development of severe COVID-19. Because the T-allele is a known risk allele for IPF, this study provides further evidence for the existence of trade-offs between optimal mucin expression levels in the aging lung.
format article
author Coline H. M. van Moorsel
Coline H. M. van Moorsel
Joanne J. van der Vis
Joanne J. van der Vis
Anna Duckworth
Chris J. Scotton
Claudia Benschop
Claudia Benschop
David Ellinghaus
David Ellinghaus
Henk J. T. Ruven
Marian J. R. Quanjel
Jan C. Grutters
Jan C. Grutters
author_facet Coline H. M. van Moorsel
Coline H. M. van Moorsel
Joanne J. van der Vis
Joanne J. van der Vis
Anna Duckworth
Chris J. Scotton
Claudia Benschop
Claudia Benschop
David Ellinghaus
David Ellinghaus
Henk J. T. Ruven
Marian J. R. Quanjel
Jan C. Grutters
Jan C. Grutters
author_sort Coline H. M. van Moorsel
title The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
title_short The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
title_full The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
title_fullStr The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
title_full_unstemmed The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
title_sort muc5b promoter polymorphism associates with severe covid-19 in the european population
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/74b3faf17a3a41a2bee1cbf580255bc2
work_keys_str_mv AT colinehmvanmoorsel themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT colinehmvanmoorsel themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT joannejvandervis themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT joannejvandervis themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT annaduckworth themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT chrisjscotton themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT claudiabenschop themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT claudiabenschop themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT davidellinghaus themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT davidellinghaus themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT henkjtruven themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT marianjrquanjel themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT jancgrutters themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT jancgrutters themuc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT colinehmvanmoorsel muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT colinehmvanmoorsel muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT joannejvandervis muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT joannejvandervis muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT annaduckworth muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT chrisjscotton muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT claudiabenschop muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT claudiabenschop muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT davidellinghaus muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT davidellinghaus muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT henkjtruven muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT marianjrquanjel muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT jancgrutters muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
AT jancgrutters muc5bpromoterpolymorphismassociateswithseverecovid19intheeuropeanpopulation
_version_ 1718406570479452160